BSEBoard Meeting7 Aug 2026 · 7 Aug 2026, 12:52 am

Krsnaa Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the unaudited standalone ....

Krsnaa Diagnostics Ltd · 543328

✦ AI SummaryResults

Krsnaa Diagnostics Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/08/2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, and to consider and evaluate the proposal for raising of funds through issuance of securities.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Krsnaa Diagnostics Ltd - 543328 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026 And Fund Raising.

Attachments (1)

📄

b5c04edb-f494-4c9c-8bed-2566e4073abf.pdf

pdf

Download →
View document text
Date: August 06, 2026 Ref. No.: KDL/SE/025/2026-27 To, To, BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Exchange Plaza, Plot No. C-1, Block G, 25th Floor, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (East) Dalal Street, Mumbai- 400001 Mumbai – 400051 Scrip Code: 543328 NSE Symbol: KRSNAA Subject: Disclosure under Regulation 29 of SEBI (LODR) Regulations, 2015 regarding Notice of the Board Meeting. Pursuant to the provisions of Regulation 29(1) & (2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, August 13, 2026 - to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter ended June 30, 2026. - to consider and evaluate the proposal for raising of funds by way of issuance of one or more instrument(s) / securities which may include equity shares, fully convertible warrants and/or any other eligible securities (convertible / non-convertible) and / or any combinations of securities thereof through permissible modes, including but not limited to a preferential issue on a private placement basis or through any other permissible mode and / or combination thereof as may be considered appropriate, in accordance with the provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 and the Companies Act, 2013, as amended, to the promoter/promoter group, subject to all such shareholders’, regulatory / statutory and other applicable approvals, if any, as may be required including conducting shareholders meeting. Pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company shall continue to remain closed until August 15, 2026 (both days inclusive). This intimation is also being uploaded on the Company’s website at https://krsnaadiagnostics.com/investors/. It is requested to take the same on your records Yours sincerely, For Krsnaa Diagnostics Limited Sujoy Sudipta Bose Company Secretary and Compliance Officer